# Formation and Severity of Pressure Ulcers Associated With 4% Albumin vs. 0.9% Sodium Chloride

> **NCT00228657** · PHASE1,PHASE2 · COMPLETED · sponsor: **Bayside Health** · enrollment: 1100 (—)

## Conditions studied

- Pressure Ulcer, Area
- Pressure Ulcer, Grade
- Albumin Level
- Risk Score
- Length of ICU Stay

## Interventions

- **DRUG:** 4% Albumin / 0.9% Sodium Chloride

## Key facts

- **NCT ID:** NCT00228657
- **Lead sponsor:** Bayside Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2003-08
- **Final completion:** 2003-08
- **Target enrollment:** 1100 (—)
- **Last updated:** 2013-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00228657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00228657, "Formation and Severity of Pressure Ulcers Associated With 4% Albumin vs. 0.9% Sodium Chloride". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00228657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*